abstract |
The invention relates to compounds according to formula (I) as autotaxin inhibitors and physiological and / or amplified, mediated and / or amplified by increased lysophosphatidic acid levels and / or activation of autotaxin. It relates to the use of such compounds for the treatment and / or prevention of pathophysiological conditions, in particular various cancers. |